Key result
External application of 50 microM RB(+)1C reduced the hKv1.5 current at +60 mV by 24+/-2% and partially relieved block induced by R-bupivacaine (61+/-2% vs 56+/-3%, P<0.05).
p-value: p=<0.05
The quaternary bupivacaine derivative RB(+)1C exerts different blocking effects on hKv1.5 channels depending on whether it is applied intracellularly or extracellularly, suggesting bupivacaine's actions result from both external and internal interactions.
Supports dual-site bupivacaine action on hKv1.5; leaves open clinical translation in cardiac electrophysiology.
Block of hKv1.5 channels by R-bupivacaine has been attributed to the interaction of the charged form of the drug with an intracellular receptor. However, bupivacaine is present as a mixture of neutral and charged forms both extra- and intracellularly. We have studied the effects produced by the R(+) enantiomer of a quaternary bupivacaine derivative, N-methyl-bupivacaine, (RB(+)1C) on hKv1.5 channels stably expressed in Ltk(-) cells using the whole-cell configuration of the patch-clamp technique. When applied from the intracellular side of the membrane, RB(+)1C induced a time- and voltage-dependent block similar to that induced by R-bupivacaine. External application of 50 microM RB(+)1C reduced the current at +60 mV by 24+/-2% (n=10), but this block displayed neither time- nor voltage-dependence. External RB(+)1C partially relieved block induced by R-bupivacaine (61+/-2% vs 56+/-3%, n=4, P<0.05), but it did not relieve block induced by internal RB(+)1C. In addition, it did not induce use-dependent block, but when applied in combination with internal RB(+)1C a use-dependent block that increased with pulse duration was observed. These results indicate that RB(+)1C induces different effects on hKv1.5 channels when applied from the intra or the extracellular side of the membrane, suggesting that the actions of bupivacaine are the resulting of those induced on the external and the internal side of hKv1.5 channels.
No takes yet. Share an insight, caveat, or question.
Longobardo et al. (2000) studied this question. R(+) enantiomer of N-methyl-bupivacaine (RB(+)1C) vs. R-bupivacaine was evaluated on Current reduction at +60 mV (p=<0.05). External application of 50 microM RB(+)1C reduced the hKv1.5 current at +60 mV by 24+/-2% and partially relieved block induced by R-bupivacaine (61+/-2% vs 56+/-3%, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: